January 14, 2020
Myeloma New Zealand is today calling on Pharmac to make good on their proposal to widen access to blood cancer treatment lenalidomide (Revlimid) from April this year, allowing eligible patients access the subsidised drug earlier in their course of treatment. As one of several groups that marched on Parliament in 2019 presenting petitions demanding an...
Continue Reading

Floor 7, 90 The Terrace
Wellington Central
New Zealand